A cervical screening test, often referred to as a Pap smear, is a procedure designed to detect abnormal cells on the cervix, the lower part of the uterus. The primary objective is to identify changes that could potentially lead to cervical cancer. For instance, the test can reveal the presence of precancerous cells caused by the human papillomavirus (HPV), which is a significant risk factor for cervical cancer.
Cervical screening plays a crucial role in preventing cervical cancer by allowing for early detection and treatment of precancerous abnormalities. Its implementation has significantly reduced the incidence and mortality rates associated with cervical cancer worldwide. The test’s widespread availability and proven efficacy make it an essential component of women’s healthcare.